|
|
The Judishapur Journal of Oncology، جلد ۲، شماره ۱، صفحات ۲۵-۲۷
|
|
|
| عنوان فارسی |
|
|
| چکیده فارسی مقاله |
|
|
| کلیدواژه‌های فارسی مقاله |
|
|
| عنوان انگلیسی |
Neoadjuvant Chemoradiotherapy for Advanced Rectal Cancer |
|
| چکیده انگلیسی مقاله |
Introduction: There is some evidence that neoadjuvant chemoradiation for stages II and III rectal tumors associated with significant greater rate of complete pathologic response and sphincter preservation. The aim of this study was to determine the outcome of neoadjuvant chemoradiation in patients with advanced rectal cancer.
Materials and Methods: In this retrospective investigation, the medical records of all patients with stage II or III that underwent neoadjuvant chemoradiation (during 2005-2010) were studied. Radiotherapy was delivered by 4500-5000cGy/25-28f for 25-28 sessions, and oral 5-FU and weekly injected Eloxatin were administered. Then, all patients underwent surgery by one expert oncologist surgeon. Data include demographic data, the kind of operation, the rate of pathologic complete response and clear surgical margins and sphincter preservation were collected. Data were analyzed with SPSS software version 14.
Results: Among70 patients, the mean age was 46±13 years and 71.5% of them were male.Ten percent had the pathologic complete response, 60% had clear surgical margins. Sphincter preservation rate in cases which the distance of the tumor from anal verge was five cm or more and in cases which it was less than five cm were 51.4% and 5.6%, respectively.
Conclusion: Our results indicated that neoadjuvant chemoradiation recommended for patients with the stages II and III rectal cancers. The advantages of this modality are relatively higher chance of complete response and anal sphincter saving procedure. |
|
| کلیدواژه‌های انگلیسی مقاله |
Neoadjuvant chemoradiation,
rectal cancer,
sphincter saving procedure,
TME |
|
| نویسندگان مقاله |
Abdolhassan Talaiezadeh |
Professor of general surgery and surgical oncology, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Petroleum & Environmental Pollutant Cancer Research Center.
Hodjatollah Shahbazian |
Assistant Professor of radiotherapy and oncology, Department of Radiotherapy and Oncology, Golestan Hospital, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran
Mohammad Hosein Sarmast Shushtari |
Professor of general surgery, Department of Surgery, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran
Seyyed Mohammad Hoseini |
Assistant Professor of radiotherapy and oncology, Department of Radiotherapy and Oncology, Golestan Hospital, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran
Seyyed Saheb Hoseininejad |
General Surgeon, Department of Surgery, Razi Hospital, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran.
|
|
| نشانی اینترنتی |
https://jjo.ajums.ac.ir/article_49333_1e9a8aa48881a2b0bb30a6463214993c.pdf |
| فایل مقاله |
فایلی برای مقاله ذخیره نشده است |
| کد مقاله (doi) |
|
| زبان مقاله منتشر شده |
en |
| موضوعات مقاله منتشر شده |
|
| نوع مقاله منتشر شده |
|
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|